Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Status:
Completed
Trial end date:
2000-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone
sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone